These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17847051)

  • 1. The influence of rigid or flexible linkage between two ligands on the effective affinity and avidity for reversible interactions with bivalent receptors.
    Bobrovnik SA
    J Mol Recognit; 2007; 20(4):253-62. PubMed ID: 17847051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors.
    Gohlke H; Klebe G
    Angew Chem Int Ed Engl; 2002 Aug; 41(15):2644-76. PubMed ID: 12203463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalent ligands with long nanometer-scale flexible linkers.
    Tian L; Heyduk T
    Biochemistry; 2009 Jan; 48(2):264-75. PubMed ID: 19113836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New capabilities in determining the binding parameters for ligand-receptor interaction.
    Bobrovnik S
    J Biochem Biophys Methods; 2005 Oct; 65(1):30-44. PubMed ID: 16188321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple and convenient approach for evaluation of the parameters of ligand-receptor interaction. Receptor blocking index and its application.
    Bobrovnik SA
    J Mol Recognit; 2008; 21(2):96-102. PubMed ID: 18383099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspanning bivalent ligands as improved surface receptor binding inhibitors of the cholera toxin B pentamer.
    Pickens JC; Mitchell DD; Liu J; Tan X; Zhang Z; Verlinde CL; Hol WG; Fan E
    Chem Biol; 2004 Sep; 11(9):1205-15. PubMed ID: 15380181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding noncovalent interactions: ligand binding energy and catalytic efficiency from ligand-induced reductions in motion within receptors and enzymes.
    Williams DH; Stephens E; O'Brien DP; Zhou M
    Angew Chem Int Ed Engl; 2004 Dec; 43(48):6596-616. PubMed ID: 15593167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-phase synthesis for the identification of high-affinity bivalent lectin ligands.
    Debenham SD; Snyder PW; Toone EJ
    J Org Chem; 2003 Jul; 68(15):5805-11. PubMed ID: 12868911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-states of receptor-ligand dynamics: a theoretical framework.
    Chaves M; Sontag ED; Dinerstein RJ
    J Theor Biol; 2004 Apr; 227(3):413-28. PubMed ID: 15019508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The logical repertoire of ligand-binding proteins.
    Graham I; Duke T
    Phys Biol; 2005 Aug; 2(3):159-65. PubMed ID: 16224121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer calculation of multiple binding equilibrium isotherms: application to the binding of bivalent ligands to antibodies interacting with cell surface Fc-receptors.
    Barbet J; Le Doussal JM; Gruaz-Guyon A; Martin M; Gautherot E; Delaage M
    J Theor Biol; 1993 Dec; 165(3):321-40. PubMed ID: 8114501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of asymmetric binding in ligand-receptor systems with 1:2 interaction ratio.
    Míguez DG
    Biophys Chem; 2010 May; 148(1-3):74-81. PubMed ID: 20332059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-tethered ligand-receptor interactions between surfaces II.
    Zhang CZ; Wang ZG
    Langmuir; 2007 Dec; 23(26):13024-39. PubMed ID: 18001063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the nature of the multivalency effect: a thermodynamic model.
    Kitov PI; Bundle DR
    J Am Chem Soc; 2003 Dec; 125(52):16271-84. PubMed ID: 14692768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complexity of complexes in signal transduction.
    Hlavacek WS; Faeder JR; Blinov ML; Perelson AS; Goldstein B
    Biotechnol Bioeng; 2003 Dec; 84(7):783-94. PubMed ID: 14708119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allovalency revisited: an analysis of multisite phosphorylation and substrate rebinding.
    Locasale JW
    J Chem Phys; 2008 Mar; 128(11):115106. PubMed ID: 18361621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel multilevel statistical method for the study of the relationships between multireceptorial binding affinity profiles and in vivo endpoints.
    Selent J; Bauer-Mehren A; López L; Loza MI; Sanz F; Pastor M
    Mol Pharmacol; 2010 Feb; 77(2):149-58. PubMed ID: 19903829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability description of ligand-receptor interactions. Evaluation of reliability of events with small and supersmall doses. I. Kinetics of ligand-receptor interactions.
    Gurevich KG; Varfolomeev SD
    Biochemistry (Mosc); 1999 Sep; 64(9):1038-48. PubMed ID: 10521721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A flexible approach to induced fit docking.
    Nabuurs SB; Wagener M; de Vlieg J
    J Med Chem; 2007 Dec; 50(26):6507-18. PubMed ID: 18031000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of linker length and flexibility on multivalent targeting.
    Shewmake TA; Solis FJ; Gillies RJ; Caplan MR
    Biomacromolecules; 2008 Nov; 9(11):3057-64. PubMed ID: 18828631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.